Skip to content
AgingResearch.News
  • HomeHome
  • SearchSearch
  • AskAsk
  • FollowingFollowing
  • SavedSaved
Join freeSign inSign inSign in
AgingResearch.NewsJoin free

Navitas Pharma

Organisation

Trials

  • NCT02709031

    Phase 1/2, Status unknown, 2022, 24 people, 15 Mar 2016, clinicaltrials.gov

PrivacyTermsContact© 2026 AgingResearch.News

    News

    See all
    Sohu reports interim success in human cellular rejuvenation trialTrialssohu.com and 1 moreER-100 glaucoma trial findings support testing higher dosesTrialsLongevity.Technology and 4 moreNew immune cell map reveals how individual immune aging trajectories divergeResearchMedical Xpress and 2 more

    Trials

    See all
    AKG and Brain Health in AgingPhase 2Registered 6 Oct 2026, University of OklahomaSafety and Preliminary Efficacy of Adipose-Derived Stem Cell Secretome in Frailty (VinVital)Phase 1Registered 2 Oct 2026, Vinmec Research Institute of Stem Cell and Gene TechnologyAI-Based Conversational Social Support for Older Adults With Heart FailureRegistered 7 Oct 2026, Chang Gung University of Science and Technology

    Trending

    See all
    Nicotinamide ribosideInterventionNicotinamide riboside did not improve early Parkinson diseasePregnancyExposureEstimated brain-age gap rises by three years in pregnancyTERTGeneBlood-cell telomerase delays premature aging in zebrafishVitamin DInterventionSevere vitamin D deficiency is linked to higher death ratesImmune responseProcessImmune cell ratio linked to healthy and disease-related aging, and 1 more story this weekMediterranean lifestyleExposureMediterranean lifestyle linked to lower risk of death

    Topics

    See all
    Mechanisms241Interventions435Biomarkers416Populations556AI & data167Industry & policy18
    • Privacy
    • Terms
    • Contact
    • © 2026 AgingResearch.News